The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Quantum dots as a platform for nanoparticle drug delivery vehicle design
Open accessAbstract
Nanoparticle-based drug delivery (NDD) has emerged as a promising approach to improving upon the efficacy of existing drugs and enabling the development of new therapies. Proof-of-concept studies have demonstrated the potential for NDD systems to simultaneously achieve reduced drug toxicity, improved bio-availability, increased circulation times, controlled drug release, and targeting. However, clinical translation of NDD vehicles with the goal of treating particularly challenging diseases, such as cancer, will require a thorough understanding of how nanoparticle properties influence their fate in biological systems, especially in vivo. Consequently, a model system for systematic evaluation of all stages of NDD with high sensitivity, high resolution, and low cost is highly desirable. In theory, this system should maintain the properties and behavior of the original NDD vehicle, while providing mechanisms for monitoring intracellular and systemic nanocarrier distribution, degradation, drug release, and clearance. For such a model system, quantum dots (QDots) offer great potential. QDots feature small size and versatile surface chemistry, allowing their incorporation within virtually any NDD vehicle with minimal effect on overall characteristics, and offer superb optical properties for real-time monitoring of NDD vehicle transport and drug release at both cellular and systemic levels. Though the direct use of QDots for drug delivery remains questionable due to their potential long-term toxicity, the QDot core can be easily replaced with other organic drug carriers or more biocompatible inorganic contrast agents (such as gold and magnetic nanoparticles) by their similar size and surface properties, facilitating translation of well characterized NDD vehicles to the clinic, maintaining NDD imaging capabilities, and potentially providing additional therapeutic functionalities such as photothermal therapy and magneto-transfection. In this review we outline unique features that make QDots an ideal platform for nanocarrier design and discuss how this model has been applied to study NDD vehicle behavior for diverse drug delivery applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Semiconductor Clusters, Nanocrystals, and Quantum Dots
Alivisatos, A. P. (1996) · Science · doi:10.1126/science.271.5251.933 · Cited by 11,528
Murray, C. B., Norris, D. J., & Bawendi, M. G. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00072a025 · Cited by 9,282
Semiconductor Nanocrystals as Fluorescent Biological Labels
Bruchez, M., Moronne, M., Gin, P., Weiss, S., & Alivisatos, A. P. (1998) · Science · doi:10.1126/science.281.5385.2013 · Cited by 8,613
Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection
Chan, W. C. W., & Nie, S. (1998) · Science · doi:10.1126/science.281.5385.2016 · Cited by 7,278
Quantum dot bioconjugates for imaging, labelling and sensing
Medintz, I. L., Uyeda, H. T., Goldman, E. R., & Mattoussi, H. (2005) · Nature Materials · doi:10.1038/nmat1390 · Cited by 6,229
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,772
Self-citationRenal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,070
Cited by
Functional Nanomaterials for Phototherapies of Cancer
Cheng, L., Wang, C., Feng, L., Yang, K., & Liu, Z. (2014) · Chemical Reviews · doi:10.1021/cr400532z · Cited by 2,425
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy
Chen, G., Roy, I., Yang, C., & Prasad, P. N. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00148 · Cited by 1,499
Lombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019) · Journal of Nanomaterials · doi:10.1155/2019/3702518 · Cited by 864
Biocompatibility of engineered nanoparticles for drug delivery
Naahidi, S., Jafari, M., Edalat, F., Raymond, K., Khademhosseini, A., & Chen, P. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.013 · Cited by 809
Zhou, J., Yang, Y., & Zhang, C.-Y. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00049 · Cited by 704
New Generation Cadmium-Free Quantum Dots for Biophotonics and Nanomedicine
Xu, G., Zeng, S., Zhang, B., Swihart, M. T., Yong, K.-T., & Prasad, P. N. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00290 · Cited by 587
Principles, mechanisms, and application of carbon quantum dots in sensors: a review
Molaei, M. J. (2020) · Analytical Methods · doi:10.1039/c9ay02696g · Cited by 584
Tang, J., Kong, B., Wu, H., Xu, M., Wang, Y., Wang, Y., Zhao, D., & Zheng, G. (2013) · Advanced Materials · doi:10.1002/adma.201303124 · Cited by 567
The development of carbon dots: From the perspective of materials chemistry
Li, S., Li, L., Tu, H., Zhang, H., Silvester, D. S., Banks, C. E., Zou, G., Hou, H., & Ji, X. (2021) · Materials Today · doi:10.1016/j.mattod.2021.07.028 · Cited by 550
Molaei, M. J. (2019) · Talanta · doi:10.1016/j.talanta.2018.12.042 · Cited by 469
Zhang, M., Xiao, B., Wang, H., Han, M. K., Zhang, Z., Viennois, E., Xu, C., & Merlin, D. (2016) · Molecular Therapy · doi:10.1038/mt.2016.159 · Cited by 456
Nanotechnology and its use in imaging and drug delivery (Review)
Sim, S., & Wong, N. (2021) · Biomedical Reports · doi:10.3892/br.2021.1418 · Cited by 454
Aqueous Based Semiconductor Nanocrystals
Jing, L., Kershaw, S. V., Li, Y., Huang, X., Li, Y., Rogach, A. L., & Gao, M. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00041 · Cited by 452
Carbon dots: Biomacromolecule interaction, bioimaging and nanomedicine
Peng, Z., Han, X., Li, S., Al-Youbi, A. O., Bashammakh, A. S., El-Shahawi, M. S., & Leblanc, R. M. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.06.001 · Cited by 411
Synthesis and applications of metal-organic framework–quantum dot (QD@MOF) composites
Aguilera-Sigalat, J., & Bradshaw, D. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2015.08.004 · Cited by 350
Engineered nanoparticles and organic matter: A review of the state-of-the-art
Grillo, R., Rosa, A. H., & Fraceto, L. F. (2015) · Chemosphere · doi:10.1016/j.chemosphere.2014.07.049 · Cited by 335
Natural carbon-based quantum dots and their applications in drug delivery: A review
Nair, A., Haponiuk, J. T., Thomas, S., & Gopi, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110834 · Cited by 329
Deng, X., Liang, S., Cai, X., Huang, S., Cheng, Z., Shi, Y., Pang, M., Ma, P., & Lin, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01716 · Cited by 319
Biocompatible Semiconductor Quantum Dots as Cancer Imaging Agents
McHugh, K. J., Jing, L., Behrens, A. M., Jayawardena, S., Tang, W., Gao, M., Langer, R., & Jaklenec, A. (2018) · Advanced Materials · doi:10.1002/adma.201706356 · Cited by 318
Carbon Quantum Dots: Properties, Preparation, and Applications
Kong, J., Wei, Y., Zhou, F., Shi, L., Zhao, S., Wan, M., & Zhang, X. (2024) · Molecules · doi:10.3390/molecules29092002 · Cited by 311
Alginate Nanoparticles for Drug Delivery and Targeting
Severino, P., da Silva, C. F., Andrade, L. N., de Lima Oliveira, D., Campos, J., & Souto, E. B. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190425163424 · Cited by 304
Chowdhuri, A. R., Singh, T., Ghosh, S. K., & Sahu, S. K. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b03988 · Cited by 296
Rationally Engineered Nucleic Acid Architectures for Biosensing Applications
Xiao, M., Lai, W., Man, T., Chang, B., Li, L., Chandrasekaran, A. R., & Pei, H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00121 · Cited by 290
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment
Xu, X., Liu, C., Wang, Y., Koivisto, O., Zhou, J., Shu, Y., & Zhang, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113891 · Cited by 289
H. R, C., Schiffman, J. D., & Balakrishna, R. G. (2018) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2017.11.189 · Cited by 286
Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles
Selby, L. I., Cortez‐Jugo, C. M., Such, G. K., & Johnston, A. P. R. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1452 · Cited by 283
Quantum dots-fluorescence resonance energy transfer-based nanosensors and their application
Stanisavljevic, M., Krizkova, S., Vaculovicova, M., Kizek, R., & Adam, V. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.06.076 · Cited by 271
Aptamers: Active Targeting Ligands for Cancer Diagnosis and Therapy
Wu, X., Chen, J., Wu, M., & Zhao, J. X. (2015) · Theranostics · doi:10.7150/thno.10257 · Cited by 258
Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles
Souri, M., Soltani, M., Moradi Kashkooli, F., & Kiani Shahvandi, M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.024 · Cited by 178
Metadata
- Authors
- Probst, C. E., Zrazhevskiy, P., Bagalkot, V., & Gao, X.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 65
- Issue
- 5
- Pages
- 703-718
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2088779155
- Cited by
- 466
- References
- 179
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.